CompletedPhase 2NCT02595905
Cisplatin With or Without Veliparib in Treating Patients With Recurrent or Metastatic Triple-Negative and/or BRCA Mutation-Associated Breast Cancer With or Without Brain Metastases
Studying Hereditary breast cancer
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- National Cancer Institute (NCI)
- Principal Investigator
- Eve T Rodler, M.DSWOG Cancer Research Network
- Intervention
- Cisplatin(drug)
- Enrollment
- 344 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2016 – 2025
Study locations (30)
- Anchorage Associates in Radiation Medicine, Anchorage, Alaska, United States
- Anchorage Radiation Therapy Center, Anchorage, Alaska, United States
- Alaska Breast Care and Surgery LLC, Anchorage, Alaska, United States
- Alaska Oncology and Hematology LLC, Anchorage, Alaska, United States
- Alaska Women's Cancer Care, Anchorage, Alaska, United States
- Anchorage Oncology Centre, Anchorage, Alaska, United States
- Katmai Oncology Group, Anchorage, Alaska, United States
- Providence Alaska Medical Center, Anchorage, Alaska, United States
- Mercy Hospital Fort Smith, Fort Smith, Arkansas, United States
- CHI Saint Vincent Cancer Center Hot Springs, Hot Springs, Arkansas, United States
- NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro, Jonesboro, Arkansas, United States
- Kaiser Permanente-Anaheim, Anaheim, California, United States
- Sutter Auburn Faith Hospital, Auburn, California, United States
- Sutter Cancer Centers Radiation Oncology Services-Auburn, Auburn, California, United States
- AIS Cancer Center at San Joaquin Community Hospital, Bakersfield, California, United States
- +15 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02595905 on ClinicalTrials.govOther trials for Hereditary breast cancer
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE1, PHASE2NCT07558733Sapanisertib and Serabelisib (PIKTOR) in Various Combinations in Patients With HR+/HER2- Advanced/Metastatic Breast CancerFaeth Therapeutics
- RECRUITINGNANCT07436312Impact of Consumption of Ultra-processed Foods in Individuals at High Risk of CancerGustave Roussy, Cancer Campus, Grand Paris
- RECRUITINGNANCT07307664Increasing Germline Genetic Testing for Patients With CancerJosh Peterson
- RECRUITINGNCT07532434A Bidirectional Cohort Study on Prophylactic Resection Surgery in Populations at Moderate-to-High Risk for Hereditary Ovarian CancerPeking University Third Hospital
- RECRUITINGNANCT07292246A Prospective CohorT Study of HandX - Assisted ENdoscopic MAstectomy: Feasibility and Safety (ATHENA I Study)Vasileios Kalles
- RECRUITINGPHASE2NCT07162298Dragon Boat Race Versus Family Unsupervised Training to Improve the Physical Function and Quality of Life in Breast Cancer PatientsFirst Affiliated Hospital of Zhejiang University
- RECRUITINGNANCT06760507Evaluating an Evidence-Based Family History Screening Program Adapted to Increase Reach and Uptake of Screening for BRCA-Associated Cancers in Rural Public Health ClinicsEmory University
- RECRUITINGNANCT05898009Contribution of Oncogenetics in Breast Cancer in Reunion Epidemiology of Breast Cancer in Reunion: Study of the Reunion Mutation on BRCA2Centre Hospitalier Universitaire de la Réunion